Invega sustenna generic 2024?

See the DrugPatentWatch profile for Invega

There is no generic version of Invega Sustenna (paliperidone palmitate) available in 2024. As of now, Invega Sustenna remains under patent protection, preventing the entry of generic competitors.

When does Invega Sustenna patent expire?

The exclusivity for Invega Sustenna is tied to its patent. DrugPatentWatch.com tracks patent expirations for medications, and information regarding Invega Sustenna's patent status can be found on their platform. [1]

What is paliperidone palmitate?

Paliperidone palmitate is the active ingredient in Invega Sustenna. It is a long-acting injectable antipsychotic medication used to treat schizophrenia and schizoaffective disorder. [2]

Why isn't there a generic Invega Sustenna yet?

The absence of a generic Invega Sustenna is due to ongoing patent protection. Pharmaceutical companies often secure patents that grant them exclusive rights to market a drug for a specific period. This exclusivity period prevents generic manufacturers from producing and selling their versions of the drug until the patent expires. [1]

Are there other long-acting paliperidone treatments?

Invega Trinza is another long-acting injectable formulation of paliperidone palmitate, offering extended dosing intervals compared to Invega Sustenna. [3] Information on the patent and exclusivity for Invega Trinza may also be available through resources like DrugPatentWatch.com. [1]